Your browser doesn't support javascript.
loading
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Magnani, Luca; Patten, Darren K; Nguyen, Van T M; Hong, Sung-Pil; Steel, Jennifer H; Patel, Naina; Lombardo, Ylenia; Faronato, Monica; Gomes, Ana R; Woodley, Laura; Page, Karen; Guttery, David; Primrose, Lindsay; Fernandez Garcia, Daniel; Shaw, Jacqui; Viola, Patrizia; Green, Andrew; Nolan, Christopher; Ellis, Ian O; Rakha, Emad A; Shousha, Sami; Lam, Eric W-F; Gyorffy, Balázs; Lupien, Mathieu; Coombes, R Charles.
Afiliação
  • Magnani L; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Patten DK; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Nguyen VT; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Hong SP; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Steel JH; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Patel N; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lombardo Y; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Faronato M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Gomes AR; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Woodley L; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Page K; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Guttery D; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Primrose L; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Fernandez Garcia D; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Shaw J; Department of Cancer Studies, University of Leicester, Leicester, UK.
  • Viola P; Laboratory of Medicine, Histopathology Department, Royal Brompton Hospital, London, UK.
  • Green A; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Budapest, HU.
  • Nolan C; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Budapest, HU.
  • Ellis IO; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Budapest, HU.
  • Rakha EA; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Budapest, HU.
  • Shousha S; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lam EW; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Gyorffy B; MTA TTK Lendület Cancer Biomarker Research Group, 2nd Department of Pediatrics, Semmelweis University and MTA-SE Pediatrics and Nephrology Research Group, Budapest, HU.
  • Lupien M; The Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Coombes RC; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
Oncotarget ; 6(26): 21878-91, 2015 Sep 08.
Article em En | MEDLINE | ID: mdl-26215677
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Proto-Oncogênicas / Receptor alfa de Estrogênio / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas Proto-Oncogênicas / Receptor alfa de Estrogênio / Proteínas de Ligação a DNA Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article